Ver Investigador - - Prisma - Unidad de Bibliometría

Luis Fernando López Cortés

Profesor Asociado CIS
lflopez@us.es
Área de conocimiento: Medicina
Departamento: Medicina
Grupo: Sin Grupo - 0 ()
Prog. doctorado: Prog.Doct.en Biología Molecular, Biomedicina e Investigac.Clínica (RD.2011)
Tipo Año Título Fuente
Artículo2024 DOLAMA 200: effectiveness and safety of a dual therapy with dolutegravir plus lamivudine in treatment-experienced HIV -1 infected real world participants in Spain Viruses
Artículo2024 The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers. JOURNAL OF CLINICAL INVESTIGATION
Artículo2023 Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2023 HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors BIOMEDICINE & PHARMACOTHERAPY
Artículo2023 Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered FRONTIERS IN IMMUNOLOGY
Artículo2023 Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy BIOMEDICINE & PHARMACOTHERAPY
Letter2023 Response to: Reply to: Anti-CD4 autoantibodies in immunological nonresponder people living with HIV: cause of CD4+ T cell depletion? AIDS
Artículo2023 Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes EBIOMEDICINE
Artículo2022 Ampicillin plus ceftriaxone combined therapy for enterococcus faecalis infective endocarditis in opat JOURNAL OF CLINICAL MEDICINE
Artículo2022 Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion? AIDS
Artículo2022 Brief report: evaluation of inflammation and atherogenesis biomarkers through 148 weeks postswitch to dolutegravir and rilpivirine in SWORD-1/SWORD-2 Journal of acquired immune deficiency syndromes (1999)
Artículo2022 Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients PLOS ONE
Artículo2022 Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people. JCI insight
Artículo2022 Immunological and inflammatory changes after simplifying to dual therapy in virologically suppressed HIV-infected patients through week 96 in a randomized trial CLINICAL MICROBIOLOGY AND INFECTION
Artículo2022 Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program DISEASES OF THE COLON & RECTUM
Artículo2022 Low CD4/CD8 ratio is associated with increased morbidity and mortality in late and non-late presenters: results from a multicentre cohort study, 2004-2018 BMC INFECTIOUS DISEASES
Artículo2022 Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: a Spanish nationwide cohort HIV MEDICINE
Artículo2022 Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV FRONTIERS IN IMMUNOLOGY
Corrección2021 Corrigendum: “Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application” (Journal of Pharmaceutical and Biomedical Analysis (2020) 189, (S0731708520313704), (10.1016/j.jpba.2020.113484)) JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Artículo2021 COVID-19 in hospitalized HIV-positive and HIV-negative patients: a matched study HIV MEDICINE
Artículo2021 Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection CELLULAR & MOLECULAR IMMUNOLOGY
Corrección2021 Erratum for Herrera-Hidalgo et al., "Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs?" ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Corrección2021 Erratum: Ampicillin and ceftriaxone solution stability at different temperatures in outpatient parenteral antimicrobial therapy (Antimicrobial Agents and Chemotherapy (2020) 64:7 (e00309-20) DOI: 10.1128/AAC.00309-20) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021 Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs? ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021 Late presentation for HIV remains a major health issue in Spain: results from a multicenter cohort study, 2004–2018 PLOS ONE
Artículo2021 Mesenchymal stromal cells in human immunodeficiency virus-infected patients with discordant immune response: early results of a phase I/II clinical trial STEM CELLS TRANSLATIONAL MEDICINE
Artículo2021 SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome Scientific reports
Artículo2020 Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020 Brief Report: CYP27B1 rs10877012 T Allele Was Linked to Non-AIDS Progression in ART-Naïve HIV-Infected Patients: A Retrospective Study Journal of acquired immune deficiency syndromes (1999)
Artículo2020 CD300a identifies a CD4+ memory T cell subset with a higher susceptibility to HIV-1 infection AIDS
Artículo2020 Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: development and application JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Artículo2020 Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study AIDS RESEARCH AND THERAPY
Artículo2020 Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study LANCET HIV
Revisión2020 Enterococcus faecalis endocarditis and outpatient treatment: a systematic review of current alternatives Antibiotics
Artículo2020 How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain HIV MEDICINE
Artículo2020 Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? CLINICAL INFECTIOUS DISEASES
Artículo2020 Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy A Cohort Study Annals of Internal Medicine
Artículo2020 Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients? JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Modulation of monocyte activation and function during direct antiviral agents treatment in HIV coinfected patients ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020 Persistent HIV-controllers are more prone to spontaneously clear HCV: a retrospective cohort study JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Artículo2020 Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017) Scientific reports
Artículo2019 DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients MEDICINE
Artículo2019 Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018) Enfermedades infecciosas y microbiología clínica
Artículo2019 High-resolution anoscopy in HIV-infected men: Assessment of the learning curve and factors that improve the performance PAPILLOMAVIRUS RESEARCH
Artículo2019 High-risk Human Papilloma Virus Testing Improves Diagnostic Performance to Predict Moderate- to High-grade Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus-infected Men Who Have Sex With Men in Low-to-Absent Cytological Abnormalities CLINICAL INFECTIOUS DISEASES
Artículo2019 Response to a reinforced hepatitis B vaccination scheme in HIV-infected patients under real-life conditions VACCINE
Artículo2019 Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Artículo2019 Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study LANCET
Artículo2018 Absolute CD4(+) T cell count overstate immune recovery assessed by CD4(+)/CD8(+) ratio in HIV-infected patients on treatment PLOS ONE
Artículo2018 Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Artículo2018 Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients JOURNAL OF INFECTIOUS DISEASES
Artículo2018 Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients MEDICINE
Nota2018 Long-term Persistent Elite HIV-controllers: The Right Model of Functional Cure EBIOMEDICINE
Artículo2018 Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Artículo2018 No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients PLOS ONE
Artículo2018 Switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from dolutegravir plus abacavir and lamivudine in virologically suppressed adults with HIV-1: 48 week results of a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial LANCET HIV
Artículo2017 HIV-1 p24 and CD4(+)T cell count during boosted protease-inhibitor monotherapy in HIV-infected patients Enfermedades infecciosas y microbiología clínica
Artículo2017 Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2017 Pharmacokinetic interactions between cobicistat-boosted elvitegravir and darunavir in HIV-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017 Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach PLOS ONE
Artículo2017 Viral Kinetics in Semen With Different Antiretroviral Families in Treatment-Naive Human Immunodeficiency Virus-Infected Patients: A Randomized Trial CLINICAL INFECTIOUS DISEASES
Letter2016 Antiretroviral Therapy in Early HIV Infection NEW ENGLAND JOURNAL OF MEDICINE
Letter2016 Early initiation of antiretroviral therapy: Debate over? LANCET INFECTIOUS DISEASES
Artículo2016 Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens PLOS ONE
Artículo2016 Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016 Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy AIDS RESEARCH AND HUMAN RETROVIRUSES
Revisión2016 Impact of HIV on the severity of influenza EXPERT REVIEW OF RESPIRATORY MEDICINE
Artículo2016 Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013 JOURNAL OF INFECTION
Artículo2016 MicroRNA profile in CD8+T-Lymphocytes from HIV-infected individuals: relationship with antiviral immune response and disease progression PLOS ONE
Artículo2016 Off-label use of rilpivirine in combination with emtricitabine and tenofovir in HIV-1-infected pediatric patients A multicenter study MEDICINE
Artículo2016 Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract CLINICAL MICROBIOLOGY AND INFECTION
Artículo2016 Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy HIV MEDICINE
Artículo2015 Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy PLOS ONE
Artículo2015 Boosted Lopinavir- Versus Boosted Atazanavir-Containing Regimens and Immunologic, Virologic, and Clinical Outcomes: A Prospective Study of HIV-Infected Individuals in High-Income Countries CLINICAL INFECTIOUS DISEASES
Artículo2015 Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study LANCET HIV
Artículo2015 Differential Effects of Viremia and Microbial Translocation on Immune Activation in HIV-Infected Patients Throughout Ritonavir-Boosted Darunavir Monotherapy MEDICINE
Artículo2015 Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2015 Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment? MEDICINE
Artículo2015 Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2015 Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy HIV MEDICINE
Artículo2015 Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection PLOS ONE
Artículo2015 Low risk of liver decompensation among human immunodeficiency virus/hepatitis C virus-coinfected patients with mild fibrosis in the short term HEPATOLOGY
Artículo2015 No Differences of Immune Activation and Microbial Translocation Among HIV-infected Children Receiving Combined Antiretroviral Therapy or Protease Inhibitor Monotherapy MEDICINE
Artículo2015 Shorter Telomere Length Predicts Poorer Immunological Recovery in Virologically Suppressed HIV-1-Infected Patients Treated With Combined Antiretroviral Therapy JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Artículo2015 Telaprevir and Ribavirin Interaction: Higher Ribavirin Levels Are Not Only Due to Renal Dysfunction during Triple Therapy ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2015 Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults CLINICAL MICROBIOLOGY AND INFECTION
Artículo2015 Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012) CLINICAL MICROBIOLOGY AND INFECTION
Artículo2014 A 24-Week Treatment Strategy With Pegylated Interferon/Ribavirin in HIV/Hepatitis C Virus Genotype 3-Coinfected Patients Who Achieved a Rapid Virologic Response Results in a High Sustained Virologic Response Rate CLINICAL INFECTIOUS DISEASES
Letter2014 Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV LANCET INFECTIOUS DISEASES
Artículo2014 Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy AIDS
Artículo2014 Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population PLOS ONE
Artículo2014 Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations PLOS ONE
Artículo2014 Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort HIV MEDICINE
Artículo2014 Darunavir minimum plasma concentration and ritonavir-boosted darunavir monotherapy outcome in HIV-infected patients ANTIVIRAL THERAPY
Artículo2014 HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients PLOS ONE
Artículo2014 Immune activation throughout a boosted darunavir monotherapy simplification strategy CLINICAL MICROBIOLOGY AND INFECTION
Artículo2014 Impact of the peginterferon-alpha 2a and ribavirin plasma levels on viral kinetics and sustained virological response in genotype 1 HCV/HIV-co-infected patients with the unfavourable non-CC IL28B genotypes JOURNAL OF VIRAL HEPATITIS
Artículo2014 Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004-2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions PLOS ONE
Artículo2014 Liver Fibrosis, Host Genetic and Hepatitis C Virus Related Parameters as Predictive Factors of Response to Therapy against Hepatitis C Virus in HIV/HCV Coinfected Patients PLOS ONE
Artículo2014 Microbial translocation and T cell activation are not associated in chronic HIV-infected children AIDS
Resumen congreso2014 Monotherapy with darunavir/ritonavir is effective and safe in clinical practice JOURNAL OF THE INTERNATIONAL AIDS SOCIETY
Artículo2014 Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries AIDS
Artículo2014 Role of Ritonavir in the Drug Interactions Between Telaprevir and Ritonavir-Boosted Atazanavir CLINICAL INFECTIOUS DISEASES
Artículo2014 Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
Artículo2013 All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010 BMC INFECTIOUS DISEASES
Artículo2013 Atazanavir-Based Therapy Is Associated with Higher Hepatitis C Viral Load in HIV Type 1-Infected Subjects with Untreated Hepatitis C AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2013 Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/Hepatitis C virus-coinfected patients with compensated cirrhosis CLINICAL INFECTIOUS DISEASES
Artículo2013 Incidence and risk factors of AIDS-defining cancers in a cohort of HIV-positive adults: Importance of the definition of incident cases Enfermedades infecciosas y microbiología clínica
Artículo2013 Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain HIV MEDICINE
Artículo2013 Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients AIDS
Artículo2013 Lopinavir Plasma Concentrations and Virological Outcome with Lopinavir-Ritonavir Monotherapy in HIV-1-Infected Patients ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013 Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008-2010 ANTIVIRAL THERAPY
Artículo2013 Risk of Liver Decompensation Among HIV/Hepatitis C Virus-Coinfected Individuals With Advanced Fibrosis: Implications for the Timing of Therapy CLINICAL INFECTIOUS DISEASES
Artículo2013 Safety profile of rilpivirine: General and neuropsychiatric tolerability, safety in patients with hepatitis B or C viruses, and lipid profile Enfermedades infecciosas y microbiología clínica
Artículo2013 The IL28B effect on hepatitis C virus kinetics among HIV patients after the first weeks of pegylated-interferon/ribavirin treatment varies according to hepatitis C virus-1 subtype AIDS
Artículo2012 Analysis of transmitted drug resistance in Spain in the years 2007-2010 documents a decline in mutations to the non-nucleoside drug class CLINICAL MICROBIOLOGY AND INFECTION
Artículo2012 Definition of Advanced Age in HIV Infection: Looking for an Age Cut-Off AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2012 Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients PLOS ONE
Artículo2012 Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms AIDS
Artículo2012 Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care ANTIVIRAL THERAPY
Artículo2012 HAVCR1 Gene Haplotypes and Infection by Different Viral Hepatitis C Virus Genotypes CLINICAL AND VACCINE IMMUNOLOGY
Artículo2012 Hepatic safety of efavirenz in HIV/hepatitis C virus-coinfected patients with advanced liver fibrosis JOURNAL OF INFECTION
Artículo2012 Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients HEPATOLOGY
Artículo2012 Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients AIDS
Artículo2012 Impact of Antiretroviral Therapy on Tuberculosis Incidence Among HIV-Positive Patients in High-Income Countries CLINICAL INFECTIOUS DISEASES
Artículo2012 Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-alpha 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients PLOS ONE
Artículo2012 Intracellular and plasma pharmacokinetics of 400 mg of etravirine once daily versus 200 mg of etravirine twice daily in HIV-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2012 Liver Toxicity of Initial Antiretroviral Drug Regimens Including Two Nucleoside Analogs Plus One Non-Nucleoside Analog or One Ritonavir-Boosted Protease Inhibitor in HIV/HCV-Coinfected Patients HIV CLINICAL TRIALS
Artículo2012 Most HIV Type 1 Non-B Infections in the Spanish Cohort of Antiretroviral Treatment-Naive HIV-Infected Patients (CoRIS) Are Due to Recombinant Viruses JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2012 Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load JOURNAL OF HEPATOLOGY
Artículo2012 Response to Pegylated Interferon Plus Ribavirin Among HIV/Hepatitis C Virus-Coinfected Patients With Compensated Liver Cirrhosis CLINICAL INFECTIOUS DISEASES
Artículo2012 The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study AIDS
Artículo2011 Improved Viral Suppression After Treatment Optimization in HIV-Infected Patients With Persistent Low-Level Viremia JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Letter2011 Linkage of the Hepatitis C Virus Genotype and Interleukin-28B Genetic Polymorphisms in Asian Patients Reply HEPATOLOGY
Artículo2011 Linkage of the Hepatitis C Virus Genotype and Interleukin-28B Genetic Polymorphisms in Asian Patients Reply HEPATOLOGY
Artículo2011 Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2011 Liver toxicity of antiretroviral combinations including Fosamprenavir plus Ritonavir 1400/100mg once daily in HIV/Hepatitis C virus-coinfected patients AIDS Patient Care and ST Ds
Artículo2011 Prevalence and resistance mutations of non-B HIV-1 subtypes among immigrants in Southern Spain along the decade 2000-2010 VIROLOGY JOURNAL
Artículo2011 Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naive HIV-infected patients (CoRIS) ANTIVIRAL RESEARCH
Letter2011 Simplified Human Immunodeficiency Virus Maintenance Therapy in Virologically Suppressed Children With Ritonavir-boosted Protease Inhibitor Monotherapy PEDIATRIC INFECTIOUS DISEASE JOURNAL
Artículo2011 The cohort of the spanish hiv research network (coris) and its associated biobank; organizational issues, main findings and losses to follow-up Enfermedades infecciosas y microbiología clínica
Revisión2011 The role of insulin resistance in HIV/hepatitis C virus-coinfected patients CURRENT OPINION IN HIV AND AIDS
Artículo2011 When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries An Observational Study Annals of Internal Medicine
Artículo2010 Concomitant nevirapine therapy is associated with higher efficacy of pegylated interferon plus ribavirin among HIV/ hepatitis C Virus-Coinfected patients Journal of AIDS and Clinical Research
Artículo2010 Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study AIDS RESEARCH AND THERAPY
Artículo2010 Increased Regulatory T Cell Counts in HIV-Infected Nonresponders to Hepatitis B Virus Vaccine JOURNAL OF INFECTIOUS DISEASES
Artículo2010 Infección por el virus de la inmunodeficiencia humana en diferentes grupos de edad: implicaciones potenciales para la prevención. Cohorte CoRIS, España, 2004-2008 MEDICINA CLINICA
Artículo2010 Nevirapine-based antiretroviral therapy is associated with lower plasma hepatitis C virus viral load among HIV/ hepatitis C Virus-Coinfected patients Journal of AIDS and Clinical Research
Artículo2010 The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals AIDS
Artículo2009 Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naive patients: results of the EPIC study (CCR100136) HIV MEDICINE
Artículo2009 Decrease in Serial Prevalence of Coinfection with Hepatitis C Virus among HIV-Infected Patients in Spain, 1997-2006 CLINICAL INFECTIOUS DISEASES
Artículo2009 Delayed Diagnosis of HIV Infection in a Multicenter Cohort: Prevalence, Risk Factors, Response to HAART and Impact on Mortality CURRENT HIV RESEARCH
Artículo2009 Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration EXPERIMENTAL EYE RESEARCH
Artículo2009 Fast Fibrosis Progression Between Repeated Liver Biopsies in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus HEPATOLOGY
Artículo2009 HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse JOURNAL OF VIRAL HEPATITIS
Artículo2009 High seroprevalence but low incidence of HCV infection in a cohort of patients with sexually transmitted HIV in Andalusia, Spain Journal of the International Association of Physicians in AIDS Care
Artículo2009 HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006) Enfermedades infecciosas y microbiología clínica
Artículo2009 Natural history of compensated hepatitis C virus-related cirrhosis in HIV-infected patients CLINICAL INFECTIOUS DISEASES
Artículo2009 Risk Factors, CD4 Long-Term Evolution and Mortality of HIV-Infected Patients who Persistently Maintain Low CD4 Counts, Despite Virological Response to HAART CURRENT HIV RESEARCH
Artículo2009 Stepped-Dose Versus Full-Dose Efavirenz for HIV Infection and Neuropsychiatric Adverse Events A Randomized Trial Annals of Internal Medicine
Artículo2009 Virological and immunological stability in HIV infected patients undergoing partial-treatment interruption JOURNAL OF CLINICAL VIROLOGY
Artículo2008 Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients JOURNAL OF HEPATOLOGY
Artículo2008 Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patients AIDS
Artículo2008 Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimen JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008 Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2008 Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
Artículo2008 Long-term assessment of didanosine, lamivudine, and efavirenz in antiretroviral-naive patients: 3-year follow-up AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2008 Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir ANTIVIRAL THERAPY
Artículo2008 Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain AIDS RESEARCH AND HUMAN RETROVIRUSES
Artículo2008 Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy CURRENT HIV RESEARCH
Artículo2008 Pharmacology, pharmacokinetic features and interactions of atazanavir Enfermedades infecciosas y microbiología clínica
Artículo2008 Role of Pegylated Interferon-alpha-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients CLINICAL PHARMACOLOGY & THERAPEUTICS
Artículo2008 Very Low Prevalence and No Clinical Significance of Occult Hepatitis B in a Cohort of HIV-Infected Patients with Isolated Anti-HBc Seropositivity: The BHOI Study HIV CLINICAL TRIALS
Artículo2007 Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy Therapeutic Drug Monitoring
Artículo2007 Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2007 Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy Therapeutic Drug Monitoring
Artículo2007 Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2007 Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients ANTIVIRAL THERAPY
Artículo2007 Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients Enfermedades infecciosas y microbiología clínica
Artículo2007 Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients ANTIVIRAL THERAPY
Artículo2007 The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection CLINICAL INFECTIOUS DISEASES
Artículo2006 Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C ANTIVIRAL THERAPY
Artículo2006 Clinical Outcome of HIV-Infected Patients with Sustained Virologic Response to Antiretroviral Therapy: Long-Term Follow-Up of a Multicenter Cohort PLOS ONE
Artículo2006 Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2006 Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2006 Efectos adversos neuropsiquiátricos asociados con efavirenz Enfermedades infecciosas y microbiología clínica
Revisión2006 Interactions that can compromise response to antiretroviral therapy Enfermedades infecciosas y microbiología clínica
Artículo2006 Pharmacological and pharmacokinetic characteristics and interactions Enfermedades Infecciosas y Microbiologia Clinica Monografias
Artículo2005 Discontinuation of antiretroviral therapy in patients with chronic HIV infection: Clinical, virologic, and immunologic consequences AIDS Patient Care and ST Ds
Artículo2005 Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
Artículo2005 Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
Artículo2005 MONITORIZACION TERAPEUTICA Y COCIENTE INHIBITORIO DE LOS FARMACOS ANTIRRETROVIRALES. ¿SON APLICABLES A NUESTRA REALIDAD?. Enfermedades infecciosas y microbiología clínica
Artículo2005 Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naive patients: The VESD study HIV CLINICAL TRIALS
Artículo2005 Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: Can they applied to the current situation? Enfermedades infecciosas y microbiología clínica
Artículo2005 Therapeutic drug monitoring of efavirenz: Trough levels cannot be estimated on the basis of earlier plasma determinations JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Editorial2004 Supresión del tratamiento antirretroviral ¿es ya una estrategia más? FARMACIA HOSPITALARIA
Artículo2003 Ensayo clínico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cutánea Enfermedades infecciosas y microbiología clínica
Letter2003 Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: Pharmacokinetics and efficacy HIV CLINICAL TRIALS
Letter2003 Once-daily saquinavir-hgc plus low-dose ritonavir (1200/100 mg) in HIV-infected pregnant women: Pharmacokinetics and efficacy HIV CLINICAL TRIALS
Letter2003 Once-daily saquinavir-sgc plus low-dose ritonavir (1200/100 mg) in combination with efavirenz: Pharmacokinetics and efficacy in HIV-infected patients with prior antiretroviral therapy JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Artículo2003 Q fever: epidemiology, clinical features and prognosis. A study from 1983 to 1999 in the South of Spain JOURNAL OF INFECTION
Capítulo2003 Trastornos oculares asociados a la infección VIH.. La infección por el VIH: guía práctica
Artículo2002 Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis CLINICAL PHARMACOKINETICS
Artículo2001 Acquired immunodeficiency syndrome-related cryptosporidial cholangitis: resolution with endobiliary prosthesis insertion GASTROINTESTINAL ENDOSCOPY
Letter2001 Cidofovir added to highly active antiretroviral therapy in AIDS-associated progressive multifocal leukoencephalopathy AIDS
Artículo2001 Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection Journal of Chromatography B: biomedical sciences and applications
Letter2001 Efavirenz plasma concentrations and efficiency AIDS
Artículo2001 Influence of the response to induction therapy on the rate of progression of cytomegalovirus retinitis in AIDS patients on intravitreal maintenance therapy EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo2001 Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
Artículo2001 RESISTENCIAS A LOS INHIBIDORES DE LA TRANSCRIPTASA INVERSA NO NUCLEÓSIDOS. Enfermedades infecciosas y microbiología clínica
Artículo2000 Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-beta, interleukin-6, and inteuleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients CRITICAL CARE MEDICINE
Artículo2000 Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbits ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter1999 Absence of changes in viral load of the human immunodeficiency virus 1 following delayed cutaneous hypersensitivity test MEDICINA CLINICA
Artículo1999 Ausencia de cambios en la viremia plasmática del virus de la inmunodeficiencia humana después de la aplicación del test de hipersensibilidad cutánea retardada MEDICINA CLINICA
Letter1999 AUSENCIA DE CAMBIOS EN LA VIREMIA PLASMÁTICA DEL VIRUS DE LA INMUNODEFICIÉNCIA HUMANA DESPUÉS DE LA APLICACIÓN DEL TEST DE HIPERSENSIBILIDAD CUTÁNEA RETARDADA MEDICINA CLINICA
Artículo1999 Etiology, clinical features and outcome of splenic microabscesses in HIV-infected patients with prolonged fever EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Artículo1999 Meningitis por Cryptococcus neoformans en pacientes con infeccion por el VIH. NEUROLOGIA
Artículo1999 Murine typhus as a common cause of fever of intermediate duration - A 17-year study in the south of Spain Archives of Internal Medicine
Revisión1998 Avances en el diagnostico y tratamiento de las infecciones causadas por Herpesvirus y virus JC Enfermedades infecciosas y microbiología clínica
Artículo1998 Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection CLINICAL INFECTIOUS DISEASES
Artículo1998 Digital necrosis due to Leishmania species infection in a patient with AIDS CLINICAL INFECTIOUS DISEASES
Letter1998 Retroperitoneal fibrosis in a patient with human immunodeficiency virus infection Archives of Internal Medicine
Letter1997 Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1997 Estudio del Foscarnet como alternativa al tratamiento antiherpético Ciencia pharmacéutica
Letter1997 Foscarnet and AIDS-associated Kaposi's sarcoma AIDS
Artículo1997 Interleukin 6 in cerebrospinal fluid of patients with meningitis is not a useful diagnostic marker in the differential diagnosis of meningitis ANNALS OF CLINICAL BIOCHEMISTRY
Artículo1996 Determination of shelf life and activation energy for tumor necrosis factor-α in cerebrospinal fluid samples CLINICAL CHEMISTRY
Editorial1996 SITUACION ACTUAL DEL TRATAMIENTO DE LA RETINITIS POR CITOMEGALOVIRUS EN PACIENTES CON SIDA Enfermedades infecciosas y microbiología clínica
Artículo1995 ADENOSINE-DEAMINASE ACTIVITY IN THE CSF OF PATIENTS WITH ASEPTIC-MENINGITIS - UTILITY IN THE DIAGNOSIS OF TUBERCULOUS MENINGITIS OR NEUROBRUCELLOSIS CLINICAL INFECTIOUS DISEASES
Artículo1995 INTERLEUKIN-1-BETA IN PLEURAL FLUIDS OF DIFFERENT ETIOLOGIES - ITS ROLE AS INFLAMMATORY MEDIATOR IN EMPYEMA CHEST
Artículo1995 INTERLEUKIN-8 IN CEREBROSPINAL-FLUID FROM PATIENTS WITH MENINGITIS OF DIFFERENT ETIOLOGIES - ITS POSSIBLE ROLE AS NEUTROPHIL CHEMOTACTIC FACTOR JOURNAL OF INFECTIOUS DISEASES
Artículo1995 MUJER CON ODINOFAGIA, DISFAGIA, TRISMO Y EMPIEMA BILATERAL Enfermedades infecciosas y microbiología clínica
Artículo1994 Antibodies to antigen A60 in cerebrospinal fluid from patients with tuberculous meningitis EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
Letter1994 TUBERCULOSIS OF THE SKULL - AN UNUSUAL MANIFESTATION Tubercle and Lung Disease
Artículo1993 MEASUREMENT OF LEVELS OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN THE CSF OF PATIENTS WITH MENINGITIS OF DIFFERENT ETIOLOGIES - UTILITY IN THE DIFFERENTIAL-DIAGNOSIS CLINICAL INFECTIOUS DISEASES
Letter1992 Agranulocytosis caused by ticlopidine NEUROLOGIA
Letter1992 Induced agranulocytosis by ticlopidine NEUROLOGIA
Artículo1992 Pneumothorax secondary to septic pulmonary emboli in tricuspid endocarditis THORAX
Letter1991 Arthropathy associated with human immunodeficiency virus REVISTA CLINICA ESPANOLA
Letter1991 Artritis séptica por Streptococcus agalactiae en paciente con cirrosis hepática. Enfermedades infecciosas y microbiología clínica
Letter1991 Multicavitating pneumonia caused by Pneumocystis carinii MEDICINA CLINICA
Letter1991 TUBERCULOUS SPLENIC ABSCESSES IN PATIENTS WITH THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME TUBERCLE
Letter1990 Lyme disease in the province of Sevilla MEDICINA CLINICA
Letter1990 Malignant form of mediterranean spotted fever: Importance of early therapy Enfermedades infecciosas y microbiología clínica
Letter1990 Muscle enzymes in human trichinosis Enfermedades infecciosas y microbiología clínica
Letter1989 Tick-Borne Relapsing Fever in Intravenous Drug Abusers JOURNAL OF INFECTIOUS DISEASES
Letter1988 Pericarditis caused by Coxiella burnetti MEDICINA CLINICA
Artículo1984 Computed tomographic brain scan findings in Q fever encephalitis NEURORADIOLOGY
Letter1984 Familial urticaria induced by cold MEDICINA CLINICA
Artículo1984 Usefulness of the indirect immunofluorescence test and the rose bengal test in the diagnosis of brucellosis REVISTA CLINICA ESPANOLA
Artículo1983 Hypokaliemic myopathy and metabolic alkalosis following topic therapy with 9-alpha-fluoroprednisolone REVISTA CLINICA ESPANOLA
Artículo1983 Leptospirosis en nuestro medio. Estudio de 17 casos. REVISTA CLINICA ESPANOLA
Artículo1983 Murine typhus: clinical and serological review of 42 cases MEDICINA CLINICA
Artículo1982 Rickettsiosis. Presentacion de 13 casos. REVISTA CLINICA ESPANOLA

Proyectos de Investigación

Fecha de inicio Fecha de fin Rol Denominación Agencia financiadora
01/01/2022 31/05/2023 Investigador/a Nuevos atributos funcionales de las células T CD4 foliculares VIH especificas en el control espontáneo del VIH en individuos controladores de elite (US-1380938) Consejería de Economía, Conocimiento, Empresas y Universidad (Autonómico)
05/10/2021 31/03/2023 Investigador/a Encapsulating agents based on the use of metal organic frameworks as new approaching to eradicate HIV (P20_01234) Consejería de Economía, Conocimiento, Empresas y Universidad (Autonómico)
El investigador no tiene ningún resultado de investigación asociado